EU regulator backs extending RoActemra use for adults with severe COVID-19

The European Union's drug regulator on Monday recommended extending the use of Roche's RoActemra for adults with COVID-19 on systemic treatment with corticosteroids and those who need oxygen support or mechanical ventilation.

migrator

Published:6th Dec, 2021 at 9:00 PM

Geneva

The European Medicines Agency (EMA) said its human medicines committee evaluated data from a main study involving over 4,000 hospitalised adults, and concluded the medicine's benefits outweigh the risks for these patients.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

EU regulator backs extending RoActemra use for adults with severe COVID-19

The European Union's drug regulator on Monday recommended extending the use of Roche's RoActemra for adults with COVID-19 on systemic treatment with corticosteroids and those who need oxygen support or mechanical ventilation.

Also Read

Finish Poonamallee-Vadapalani Metro stretch by Feb: CM Stalin

Chennai: New bridge, ABC centre in Manali zone to ease public woes

Anbumani alleges corruption behind TN's pvt power deals; flays lack of vision

Sri Lanka must embrace federalism, ensure Tamil rights: S Ramadoss

TN BJP chief Nainar alleges selective curbs on Hindu rituals